TITLE

Hemodialysis: Quality From Within

AUTHOR(S)
A., Tu; L., Lawson; S., Greco; C., Freeland; C., Allen
PUB. DATE
April 2008
SOURCE
Critical Care Nurse;Apr2008, Vol. 28 Issue 2, pe9
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Hemodialysis: Quality From Within," by A. Tu, L. Lawson et al. is presented.
ACCESSION #
31609364

 

Related Articles

  • Dialysis by the numbers. Brink, Susan // U.S. News & World Report;2/14/94, Vol. 116 Issue 6, p58 

    Examines how better monitoring might keep more kidney patients alive. Number of Americans who receive dialysis; Study in the September 30, 1993 `New England Journal of Medicine' which found that many patients were getting inadequate dialysis, increasing the risk of death by 28%; Quantity versus...

  • Erratum to "Optimal Hemodialysis Prescription: Do Children Need More Than a Urea Dialysis Dose?". Fischbach, Michel; Zaloszyc, Ariane; Schaefer, Betti; Schmitt, Claus Peter // International Journal of Nephrology;2011, p1 

    A correction to the article "Optimal Hemodialysis Prescription: Do Children Need More Than a Urea Dialysis Dose?," that appeared in the November 15, 2011 issue of the "International Journal of Nephrology" is presented.

  • Microrganismos isolados de pacientes em hemodiálise por cateter venoso central e evolução clínica relacionada. Esmanhoto, Cibele Grothe; Taminato, Mônica; Fram, Dayana Souza; Silva Belasco, Angélica Gonçalves; Barbosa, Dulce Aparecida // Acta Paulista de Enfermagem;2013, Vol. 26 Issue 5, p413 

    Objective: To identify the microorganisms isolated on the pericatheter skin, catheter tip and blood stream of patients on hemodialysis by central venous catheter, to verify the profile of sensitivity of these microorganisms to antimicrobials and to assess the clinical evolution and mortality...

  • Living day-to-day with kidney dialysis. Williams, Rebecca D. // FDA Consumer;Jan/Feb98, Vol. 32 Issue 1, p11 

    Focuses on quality improvements of hemodialysis centers in the United States due to consistent studies showing that American dialysis patients do not live as long as those in other countries. Sample experiences of Tony Robinson, a dialysis patient from Florida; Response of the National Kidney...

  • Book and Media Reviews. Handbook of Dialysis 5th Edition. Brooks, Deborah H. // Nephrology Nursing Journal;May/Jun2015, Vol. 42 Issue 3, p295 

    No abstract available.

  • Infections Associated with Use of the LifeSite Hemodialysis Access System. Ross, John J.; Narayan, Geetha; Bergeron, Ellen K.; Worthington, Michael G.; Strom, James A. // Clinical Infectious Diseases;7/1/2002, Vol. 35 Issue 1, p93 

    We observed infection rates associated with the LifeSite Hemodialysis Access System, a novel dialysis device consisting of 2 subcutaneously implanted valves accessed by repeated use of fibrous tissue tracts, of 4.8 total infections and 8.1 first episodes per 1000 patient-days. These rates are...

  • Hemodialysis in the Home. Eschbach Jr., J. W.; Barnett, B. M. S.; Daly, S.; Cole, J. J.; Scribner, B. H. // Annals of Internal Medicine;Dec67, Vol. 67 Issue 6, p1149 

    Describes the evolution of home hemodialysis program. Technique of home hemodialysis; Patient training program; Medical aspects of home dialysis; Problems during dialysis; Advantages of home dialysis for the patient.

  • Daily hemodialysis and nutritional status. Goffin, Eric; Pirard, Yolande; Francart, Julie; Vignioble, Mercedes; Goovaerts, Tony; Robert, Annie; Pirson, Yves // Kidney International;May2002, Vol. 61 Issue 5, p1909 

    Focuses on the impact of hemodialysis on the nutritional status of the patient. Comparison between the efficacy of conventional hemodialysis (CHD) and daily hemodialysis; Improvements in lean body mass; Use of the treatment in CHD patients with poor nutritional status.

  • Alternative Dialysis Therapies - Why All the Interest? Doss-McQuitty, Sheila // Nephrology Nursing Journal;Jan/Feb2013, Vol. 40 Issue 1, p17 

    Alternative dialysis therapies offer options for improving the dialysis care and lives of patients. This article reviews the available therapies and presents patient-related reasons for offering these therapies. It is through these therapies that we can make a positive difference for patients.

  • Un-willingness to pay for adverse drug event regulatory actions.  // Reactions Weekly;11/5/2011, Issue 1376, p4 

    The article discusses a study by researchers from Erasmus University Rotterdam and Utrecht University which examined the willingness of Dutch dialysis patients to pay limited amounts to reduce the risk of side effects associated with epoetin alfa use.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics